For volunteers

Healthy volunteer studies in Romania

24 open studies in the registries that take healthy volunteers and have a site in Romania.

Phase 1Starts 1 Oct 2026
Ages 18 to 64All sexes112 participants
2026-525799-25-00
An open label, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine delayed release capsules 400 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Mesalamine Delayed-Release Capsules 400 mg, manufactured for Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, in healthy, adult, human subjects under fed condition.
Cluj-Napoca · Sun Pharmaceutical Industries Limited
Registry updated 12 Oct 2026
Registry record: EU CTIS
Phase 1Starts 1 May 2026
Ages 18 to 64All sexes36 participants
2025-524935-38-00
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Imatinib Mesylate Tablets 400 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Glivec® (Imatinib mesylate) Coated tablets 400 mg, Produced by Novartis Pharma Produktions GmbH, Wehr, Germany or Novartis Pharmaceutical Manufacturing LLC, Ljubljana; Imported and Registered by Novartis Biosciences SA, Prof. Vicente Rao Avenue, 90, Sao Paulo – SP, CNPJ: 56.994.502/0001-30, Brazilian Industry, in healthy adult, human subjects under fed condition.
Cluj-Napoca · Sun Pharmaceutical Industries Limited
Registry updated 7 Sept 2026
Registry record: EU CTIS
Phase 1Starts 5 Feb 2026
From age 18All sexes44 participants
2025-520978-18-00
A Participant- and Investigator--Blinded, Placebo-Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants with Chronic Kidney Disease
Cluj-Napoca, Bucharest · Novartis Pharma AG
Registry updated 20 Jul 2026
Registry record: EU CTIS
Phase 1Starts 1 Jun 2026
Ages 18 to 64All sexes72 participants
2025-523410-84-00
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover, bioavailability study comparing Bupropion Hydrochloride Extended Release Capsules 150 mg, Manufactured by Sun Pharmaceutical Industries Limited, India with WELLBUTRIN XL (Bupropion hydrochloride) extended release tablets 300 mg, Distributed by: Bausch Health US, LLC Bridgewater, NJ 08807 USA. Manufactured by: Bausch Health Companies, Inc. Steinbach, MB R5G 1Z7, Canada, in healthy, adult, human subjects under fasting condition.
Cluj-Napoca · Sun Pharmaceutical Industries Limited
Registry updated 5 May 2026
Registry record: EU CTIS
Phase 1Starts 1 Jun 2026
Ages 18 to 64All sexes72 participants
2025-523411-11-00
An open label, balanced, randomized, three treatment, three period, three sequence, single dose, crossover study to assess the effect of food and effect of apple sauce on bioavailability of the Test product (Bupropion Hydrochloride Extended Release Capsules 150 mg, manufactured by Sun Pharmaceutical Industries Limited, India) in healthy, adult, human subjects.
Cluj-Napoca · Sun Pharmaceutical Industries Limited
Registry updated 5 May 2026
Registry record: EU CTIS
Phase 1Starts 1 Sept 2026
Ages 18 to 64All sexes72 participants
2025-524267-20-00
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover bioequivalence study comparing Trametinib tablets 2 mg, Manufactured by Sun Pharmaceutical Industries Limited, India with MEKINIST® (Trametinib) tablets 2 mg, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA in healthy, adult, human subjects under fasting condition.
Cluj-Napoca · Sun Pharmaceutical Industries Limited
Registry updated 30 Apr 2026
Registry record: EU CTIS
Phase 1Starts 3 Jan 2026
Ages 18 to 64All sexes112 participants
2025-522106-20-00
A double blinded, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine Delayed Release Tablets USP 1.2 g manufactured by Sun Pharmaceutical Industries Limited, India with Mezavant (mesalamine) Delayed and Extended-Release Tablets 1.2 g product of Takeda Canada Inc., in healthy, adult, human subjects under fasting condition.
Cluj-Napoca · Sun Pharmaceutical Industries Limited
Registry updated 1 Sept 2025
Registry record: EU CTIS
Phase 1Starts 3 Jan 2026
Ages 18 to 64All sexes168 participants
2025-521598-16-00
A double blinded, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine Delayed Release Tablets USP 1.2 g manufactured by Sun Pharmaceutical Industries Limited, India with Mezavant (mesalamine) Delayed and Extended-Release Tablets 1.2 g product of Takeda Canada Inc., in healthy, adult, human subjects under fed condition.
Cluj-Napoca · Sun Pharmaceutical Industries Limited
Registry updated 22 Jul 2025
Registry record: EU CTIS
No phaseStarts Sept 2025
Ages 10 to 19All sexes4000 participants
NCT06931847
SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
Cluj-Napoca · Biobizkaia Health Research Institute
Registry updated 17 Apr 2025
Registry record: ClinicalTrials.gov
No phaseStarts Sept 2025
Ages 14 to 18All sexes3500 participants
NCT06922201
The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program
Cluj-Napoca · Biobizkaia Health Research Institute
Registry updated 10 Apr 2025
Registry record: ClinicalTrials.gov
Phase 1/2Starts 10 Oct 2024
Ages 18 to 75All sexes270 participants
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Bragadiru, Bucharest, Ploieşti, Timișoara, Cluj-Napoca · Xencor, Inc.
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Phase 1/2Starts 31 Jan 2025
Ages 18 to 75All sexes400 participants
NCT06842186
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
Cluj-Napoca, Bucharest · Wave Life Sciences USA, Inc.
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.gov
Phase 1Starts 13 Oct 2026
Ages 18 to 64All sexes112 participants
2026-525798-38-00
An open label, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine delayed release capsules 400 mg manufactured by Sun Pharmaceutical Industries Limited, India with Mesalamine Delayed-Release Capsules 400 mg, manufactured for Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, in healthy, adult, human subjects under fasting condition.
Cluj-Napoca · Sun Pharmaceutical Industries Limited
Registry updated 12 Oct 2026
Registry record: EU CTIS
Phase 1/2Starts 18 Sept 2025
From age 18All sexes89 participants
2024-513613-12-00
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Târgu Mureş, Bucharest, Cluj-Napoca, Timișoara · Novartis Pharma AG
Registry updated 4 Sept 2026
Registry record: EU CTIS
Phase 1/2Starts 24 Oct 2024
Ages 18 to 100All sexes232 participants
NCT06649110
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Bucharest, Timișoara · Novartis Pharmaceuticals
Registry updated 21 Jul 2026
Registry record: ClinicalTrials.gov
No phaseStarts 15 Feb 2026
From age 18All sexes25 participants
NCT07491848
Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
Craiova · Research Center of Periodontal-Systemic Interactions
Registry updated 25 Mar 2026
Registry record: ClinicalTrials.gov
No phaseStarts 29 Sept 2021
From age 18Men only2130 participants
NCT04895839
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
Cluj-Napoca · Gabriela Ilie
Registry updated 18 Mar 2026
Registry record: ClinicalTrials.gov
No phaseStarts 1 Oct 2025
From age 18All sexes5200 participants
NCT06900829
#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
Bucharest · Casper Rokx
Registry updated 12 Mar 2026
Registry record: ClinicalTrials.gov
Phase 1/2Starts 22 Sept 2025
Ages 18 to 50All sexes50 participants
NCT07399626
Adaptation and Validation of the Hypomanic Personality Scale (HPS-6) to Romanian
Cluj-Napoca · Babes-Bolyai University
Registry updated 10 Feb 2026
Registry record: ClinicalTrials.gov
No phaseStarts 19 Mar 2025
Ages 20 to 70All sexes180 participants
NCT07141043
Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients
Iași · Grigore T. Popa University of Medicine and Pharmacy
Registry updated 26 Aug 2025
Registry record: ClinicalTrials.gov
No phaseStarts 10 Jul 2020
Ages 1 to 80All sexes300 participants
NCT05982119
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
Bucharest · Centre Hospitalier Universitaire de Liege
Registry updated 20 May 2025
Registry record: ClinicalTrials.gov
No phaseStarts 1 Jan 2019
From age 18All sexes66 participants
NCT06867172
Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma
Bucharest · Carol Davila University of Medicine and Pharmacy
Registry updated 10 Mar 2025
Registry record: ClinicalTrials.gov
No phaseStarts 15 Sept 2024
Ages 0 to 14All sexes100 participants
NCT06815588
Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring
Bucharest · Research Center Borstel
Registry updated 7 Feb 2025
Registry record: ClinicalTrials.gov
No phaseStarts 4 Mar 2024
Ages 30 to 34All sexes6800 participants
NCT06275204
H. Pylori Screen-and-treat Study in a Population of Young Adults
Cluj-Napoca · University of Latvia
Registry updated 5 Mar 2024
Registry record: ClinicalTrials.gov

Other countries

Search the registries directly

Report an error